Document Detail

Trial of Edmonston-Zagreb measles vaccine in infants aged under nine months.
MedLine Citation:
PMID:  1818384     Owner:  NLM     Status:  MEDLINE    
Due to the recent finding that most infants in developing countries have lost maternal antibody for measles before nine months of age, immunization of infants younger than the recommended age of nine months would help reducing the incidence of measles in these endemic areas. We conducted a trial of Edmonston-Zagreb measles vaccine which is the strain that may be more immunogenic in young infants than the widely used Schwarz strain. Forty-five infants with mean age of 25 weeks received a dose of Edmonston-Zagreb vaccine. Antibody levels were measured, using plaque neutralization test, before and about 3 months after vaccination at which mean age was 38 weeks. The seroconversion rate was 89%. Only two infants (4.4%) had immunity before vaccination. Fifteen infants (33.33%) reported some adverse reactions including fever (13.33%), rhinorrhea (8.89%), rash (4.44%) and local reactions (22.22%). All of the reactions resolved spontaneously. We conclude that Edmonston-Zagreb measles vaccine is efficacious and safe in infants aged under nine months.
V Pongrithsukda; R Gluck; S Suwatanapongched; P Kaewmalung; J Muyakul
Related Documents :
24356454 - New reference values for calcium.
7761184 - Perinatal transmission and manifestation of hepatitis c virus infection in a high risk ...
24979974 - Infant mortality statistics from the 2009 period linked birth/infant death data set.
21165814 - Life-threatening hypernatremic dehydration in a 7-week-old exclusively breastfed infant...
17587674 - Sialyl oligosaccharides of human colostrum: changes in concentration during the first t...
17065474 - Optic disk size and optic disk-to-fovea distance in preterm and full-term infants.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  The Southeast Asian journal of tropical medicine and public health     Volume:  22     ISSN:  0125-1562     ISO Abbreviation:  Southeast Asian J. Trop. Med. Public Health     Publication Date:  1991 Sep 
Date Detail:
Created Date:  1992-07-16     Completed Date:  1992-07-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0266303     Medline TA:  Southeast Asian J Trop Med Public Health     Country:  THAILAND    
Other Details:
Languages:  eng     Pagination:  347-50     Citation Subset:  IM    
Department of Pediatrics, Maharaj Nakhon Ratchasima Hospital, Thailand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age Factors
Immunity, Active
Immunity, Maternally-Acquired
Measles / blood,  epidemiology,  prevention & control*
Measles Vaccine / administration & dosage,  adverse effects,  therapeutic use*
Neutralization Tests
Thailand / epidemiology
Reg. No./Substance:
0/Measles Vaccine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparison of an IgM capture ELISA with a dot enzyme immunoassay for laboratory diagnosis of dengue ...
Next Document:  Impact of a tetanus toxoid immunization mass campaign on neonatal tetanus mortality in Aceh Province...